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Abstract Sneddon’s syndrome is a rare vascular disease
affecting mainly skin and brain arterioles leading to their
occlusion due to excessive endothelial proliferation. The
two main features of this syndrome are livedo reticularis
and lacunar subcortical infarcts. Here, we describe the case
of a 64-year-old woman presenting with a 4-year history of
a throbbing, bilateral, parieto-occipital headache associated
with facial pain, but without any other accompanying
symptom. The pain, initially misdiagnosed as atypical tri-
geminal neuralgia, worsened up to chronic daily and such
severely disabling headache that she was constrained to
bed. She presented with reduced cognitive functions, dif-
fuse and severe livedo reticularis, severe myalgias and mild
stiffness. All diagnostic test for different diseases were
performed and other diseases excluded except for Sned-
don’s syndrome. Her symptoms were reduced firstly using
acetylsalicylic acid, then ticlopidine 250 mg bid was
begun and then Pentoxyphillin, resulting in a significant
improvement of symptoms with the disappearance of
headache. Her worsening in the first year was characterized
by obsessive-compulsive behaviours, body-image misper-
ceptions and panic attacks, improved for a period using
olanzapine. Considering this case, we remark the impor-
tance of using headache classification to avoid diagnostic
errors, secondly, we describe an atypical manifestation of
Sneddon’s syndrome and therapeutic efficacy of using
ticlopidine and pentoxyphillin.
Introduction
Sneddon’s syndrome is a rare, progressive, non-inflamma-
tory vasculopathy affecting the small- and medium-size
arteries of the brain and skin, leading to their occlusion due
to excessive endothelial proliferation. The two main fea-
tures of this syndrome are livedo reticularis and lacunar
subcortical infarcts. Other frequent symptoms are dementia,
heart valvulopathy, hypertension and renal failure [1, 2].
Case report
Here we describe the case of a 64-year-old woman presenting
with a 4-year history of a de-novo throbbing, bilateral, pa-
rieto-occipital headache associated with facial pain, but
without any other accompanying symptom (phono-, photo-
phobias, nausea nor vomiting); headache worsened in ortho-
statism and improved in clinostatism. The pain, initially
misdiagnosed as atypical trigeminal neuralgia, worsened up
to chronic daily and such severely disabling headache that
she was constrained to bed. Several drugs had been used in
the previous 4 years, without any effect (benzodiazepine,
Ca-antagonist, central smooth-relaxant, tricyclic antide-
pressants, antiepileptic drugs, SSRI); she treated pain daily
with non-steroidal anti-inflammatory drugs or tramadol,
without pain improvement.
Other symptoms were reduced cognitive functions, dif-
fuse and severe livedo reticularis that persisted since she
was a young adult (Fig. 1), and severe myalgias and mild
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stiffness that progressively worsened in the previous years.
The patient had a history of mild hypertension, well con-
trolled by enalapril 10 mg, and a strong family history of
headache. Her mother showed livedo reticularis and died
when she was about 60 years old for cardiac valvulopathy
and dementia. Two sisters showed mild livedo reticularis
and myalgias. Physical examination revealed reduced skin
elasticity with slight hypomimia, palmar erythema, malar
rash, and widespread red dermographism. A pronounced
livedo was present on arms, legs, trunk and neck, inde-
pendently from patient position or room temperature.
Neurologic examination revealed only slight lower left
facial weakness and mild impairment of multiple cognitive
domains (memory, attention, problem solving, and abstract
reasoning). No other symptoms suggestive of particular
forms of arteritis, or sleep disorders were referred. Cardiac
and sovra-aortic vessels pathologies were excluded.
A general, metabolic and endocrinological blood
examination was normal, antiviral antibodies (hepatitis B
and C, and HIV) were absent and serology for syphilis was
negative, antiphospholipid antibodies (lupus anticoagulant,
anticardiolipin antibodies, anti-beta2-glycoprotein anti-
bodies, anti-S-protein coagulant antibodies) were absent,
an immunological screening was normal (antinuclear
antibodies, antineutrophil cytoplasmic antibodies, anti-
double-stranded-DNA antibodies, C3, C4, cryoglobulins,
serum immunoelectrophoresis) and other autoantibodies
were absent; test for antiphospholipid syndrome and
immunity were repeated several times, at least at 12-week
intervals. A gadolinium-enhanced MRI showed the pres-
ence of wide subcortical lacunar and confluent infarcts
(Fig. 2), while MR angiography sequences were unre-
vealing. Nerve conduction studies provided normal results.
Electromyogram showed only a mild and aspecific bilateral
myopathic impairment from proximal arm muscles. By
echocardiography, a mild mitral insufficiency was dis-
closed. Skin biopsy did not show any specific finding. In
periumbilical fat specimens, no amyloid deposits were
revealed. Genetic screening for CADASIL was negative.
CSF was normal and isoelectrofocusing did not disclose
any abnormal finding. We then diagnosed a Sneddon’s
syndrome without antiphospholipid antibodies and began
treating the patient accordingly. Our patient was first
treated with acetylsalicylic acid, 150 mg daily. All the
previous therapies were progressively (2 months) discon-
tinued. This treatment reduced only partially symptom
severity in about 1 month. Aspirin was then discontinued
and ticlopidine 250 mg bid was begun, resulting in a sig-
nificant improvement of symptoms with the disappearance
of headache. Pentoxyphillin was then added at the dose of
400 mg bid. The patient then reported well-being that
lasted about a month when she began to develop obsessive-
compulsive behaviours, body-image misperceptions and
panic attacks. These psychiatric symptoms were treated
adding olanzapine, at the dose of 15 mg daily; olanzapine
dose was then gradually reduced during the following
6 months for well-being. The patient did not show head-
ache or main cognitive impairment for the following
12 months, her livedo reticularis was less evident and only
mild myalgias persist, without need for analgesics. After
12 months of well-being, quite abruptly, the patient relapsed
Fig. 1 Livedo reticularis in our patient
Fig. 2 MRI T2 sequence of our patient shows several lacunar lesions
in the sub-cortical brainregion
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showing again dementia (temporo-spatial disorientation,
decreased attention, memory, logic, and apraxia), severe
psychiatric symptoms, myalgias and worsened livedo reticu-
laris, but no headache. Only a slight improvement was
achieved switching antiplatelet therapy to clopidogrel 75 mg
daily, increasing pentoxiphillin up to 600 mg tid and olan-
zapine up to 20 mg daily.
Discussion
Two main observations could be inferred from this case.
First, we remark the importance of using headache classi-
fication to avoid diagnostic errors. Second, we describe an
atypical manifestation of Sneddon’s syndrome. Headache
disorders are widely described in the last international
classification [3]. This classification has mainly been con-
ceived to avoid errors and misdiagnoses. In this case the
patient has not been properly treated for a 4-year period and
an atypical bilateral trigeminal neuralgia was diagnosed.
This is an example of how it is important to sift through a
patient’s signs and symptoms when diagnostic criteria are
not met in order to hypothesise a different disorder and
modify treatment accordingly. A few papers tried to eval-
uate a possible association between migraine and Sneddon’s
syndrome, but available literature is not conclusive [4].
Headache has never been described as the main symptom,
but has only been cited as an accompanying one [2]. This
case stands out for the atypical presentation with severe,
persistent, very long-lasting, disabling headache, long time
before other neurological symptoms and signs mani-
fested. Mechanism of headache pathogenesis in patients
with antiphospholipid antibodies or other coagulative dis-
orders is supposed to be ‘‘vascular’’ but it is less clear when
such antibodies are absent [4]. Classic pathologic findings
are thrombosis and recanalization in medium-small vessels
and meningeal vessels, both in patients with and without
antiphospholipid antibodies [4]. Sneddon’s syndrome is
usually treated with antiplatelet or anticoagulant therapy,
depending mainly on the presence or absence of anti-
phospholipid antibodies. A recent review does not show any
significant difference in the prognosis of the patients fol-
lowing the two treatments [1]. In our case antiplatelet
therapy was crucial and was associated with a durable pain-
free period. Unfortunately, Sneddon’s syndrome is a pro-
gressive disease and no causative therapy is yet known.
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